Children's hospitals manage drug shortages by addressing unique pediatric needs and operational challenges to ensure safe, effective care.

Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics licence application for a once weekly subcutaneous initiation dose ...

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

For 95 years, Visayan Surety and Insurance Corporation has helped Filipinos recover from fires, typhoons, earthquakes and ...

Property giant Megaworld Corp. is set to reinvest over P5 billion raised from block sales of MREIT Inc. shares over the past ...

Therapeutic Guidelines Limited (TGL), a not-for-profit publisher of clinical treatment advice, has unveiled the 10th edition ...

Outdoor grilling creates a sensory experience that elevates simple meals into memorable occasions through heat, aroma, ...

A distributed “hub-and-spoke” operation could register as one establishment, reducing administrative friction while improving ...

After Jaylen Brown's trade to the 76ers shocked the NBA world, Nick Nurse is excited for Philly's new look and ceiling.

The Port of Cleveland's revolving Economic Growth Fund will provide alternative financing for everything from industrial ...

Daniel Cressy, 23, has become the first person in the Gulf South to become functionally cured of sickle cell disease using ...

(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...